Literature DB >> 21184539

Family coronary heart disease: a call to action.

H Robert Superko1, Robert Roberts, Brenda Garrett, Lakshmana Pendyala, Spencer King.   

Abstract

A family history of coronary heart disease (CHD) is an accepted risk factor for cardiovascular events and is independent of common CHD risk factors. Advances in the understanding of genetic influences on CHD risk provide the opportunity to apply this knowledge and improve patient care. Utility of inherited cardiovascular risk testing exists by utilizing both phenotypes and genotypes and includes improved CHD risk prediction, selection of the most appropriate treatment, prediction of outcome, and family counseling. The major impediment to widespread clinical adoption of this concept involves un-reimbursed staff time, educational needs, access to a standardized and efficient assessment mechanism, and privacy issues. The link between CHD and inheritance is indisputable and the evidence strong and consistent. For clinicians, the question is how to utilize this information, in an efficient manner, in order to improve patient care and detection of high-risk family members.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21184539      PMCID: PMC6652855          DOI: 10.1002/clc.20684

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  35 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 3.  Personalized genomic medicine: a future prerequisite for the prevention of coronary artery disease.

Authors:  Robert Roberts; Alexandre Fr Stewart
Journal:  Am Heart Hosp J       Date:  2006

4.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.

Authors:  A Zambon; J E Hokanson; B G Brown; J D Brunzell
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

5.  Subclinical calcified atherosclerosis in men and its association with a family history of premature coronary heart disease in first- and second-degree relatives.

Authors:  Allen J Taylor; Joey Bindeman; Saroj Bhattarai; Irwin M Feuerstein; Patrick G O'Malley
Journal:  Prev Cardiol       Date:  2004

6.  Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals.

Authors:  A Loktionov; S Scollen; N McKeown; S A Bingham
Journal:  Br J Nutr       Date:  2000-12       Impact factor: 3.718

7.  Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.

Authors:  H Robert Superko; Mark E McGovern; Elaine Raul; Brenda Garrett
Journal:  Am J Cardiol       Date:  2004-09-01       Impact factor: 2.778

8.  Familial lipoprotein disorders in patients with premature coronary artery disease.

Authors:  J J Genest; S S Martin-Munley; J R McNamara; J M Ordovas; J Jenner; R H Myers; S R Silberman; P W Wilson; D N Salem; E J Schaefer
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

9.  Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history.

Authors:  Khurram Nasir; Erin Donnelly Michos; John A Rumberger; Joel B Braunstein; Wendy S Post; Matthew J Budoff; Roger S Blumenthal
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

10.  The relationship of reported parental history to the incidence of coronary heart disease in the Western Collaborative Group Study.

Authors:  R I Sholtz; R H Rosenman; R J Brand
Journal:  Am J Epidemiol       Date:  1975-10       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.